Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Make your choice for the sweet that transports you to its nation of beginning! - 2The most effective method to Settle on Informed Conclusions about Senior Insuranc.
- 3The cheap health insurance promoted by Trump officials has this catch
- 43 Must-Change Settings for iPhone Clients: Safeguard Yourself !
- 5Gauging the Upsides and downsides of Visas: A Complete Aide
- Which Brilliant Home Gadget Can't You Reside Without?
- Telescope in Chile captures stunning new picture of a cosmic butterfly
- Self-sacrificing ants highlight the unity of their colony, say researchers
- Russia patents space station designed to generate artificial gravity
- African nations push to recognize crimes of colonialism in Algeria
- In the background: Visiting Notable Film Areas All over the Planet
- Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says
- A Colombian city swaps iconic horse buggies for electric carriages amid animal welfare concerns
- Greenland’s melting ice and landslide-prone fjords make the oil and minerals Trump is eyeing dangerous to extract
